Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures
Author:
Funder
Sunovion
Publisher
Elsevier BV
Subject
Clinical Neurology,Neurology
Reference30 articles.
1. Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: a subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures;Abou-Khalil;Epilepsy Res.,2018
2. Psychiatric and cognitive adverse events: a pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures;Andermann;Epilepsy Behav.,2018
3. Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy;Ben-Menachem;Epilepsy Res.,2010
4. BIAL – Portela & Ca_ SA. Zebinix® (eslicarbazepine acetate). Summary of Product Characteristics https://www.medicines.org.uk/emc/product/4460/smpc 2020.
5. Adjunctive eslicarbazepine acetate: a pooled analysis of three phase III trials;Biton;Epilepsy Behav.,2017
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antiseizure Medication-Induced Alopecia: A Literature Review;Medicines;2023-06-09
2. Time to baseline seizure count in patients with focal seizures receiving adjunctive eslicarbazepine acetate in a phase IV clinical trial;Clinical Neurology and Neurosurgery;2023-02
3. Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam in the long-term care setting in the USA;Journal of Comparative Effectiveness Research;2022-12
4. Current trends and hotspots in drug-resistant epilepsy research: Insights from a bibliometric analysis;Frontiers in Neurology;2022-11-03
5. Adjunctive Treatment With Eslicarbazepine Acetate for Adults and Children With Focal-Onset Epilepsy: A Meta-Analysis;Frontiers in Neurology;2022-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3